Global Cataract Surgery Devices Market Forecast to Reach USD 12.47 Billion by 2033
Rising cataract prevalence among the aging population and technological advancements in surgical devices drive steady market growth.

Introduction
According to Renub Research Latest Report cataract surgery devices market is projected to grow from USD 8.91 billion in 2024 to USD 12.47 billion by 2033, registering a CAGR of 3.80% between 2025 and 2033. This steady growth is fueled by the increasing prevalence of cataracts in elderly populations, advancements in surgical technologies, and rising awareness of vision restoration procedures.
Cataract surgery is among the most commonly performed surgical procedures worldwide. Cataracts occur when the natural lens of the eye becomes cloudy, impairing vision. Surgical interventions involve removing the clouded lens and replacing it with an intraocular lens (IOL), often improving vision and quality of life dramatically. Modern cataract surgery devices include phacoemulsification systems, femtosecond lasers, IOLs, ophthalmic viscoelastic devices, and micro-surgical instruments, which ensure precision, safety, and efficacy during surgery.
Technological advancements, such as premium multifocal and toric lenses, allow surgeons to correct additional refractive errors like astigmatism, making cataract surgery more comprehensive than ever before.
Market Overview
Cataract surgery devices are essential tools in ophthalmology, providing accurate, safe, and minimally invasive methods for vision restoration. The market is segmented by product type, end use, and geography, offering multiple growth opportunities for device manufacturers.
Product types: Intraocular lenses, phacoemulsification systems, femtosecond lasers, ophthalmic viscoelastic devices, and other consumables.
End users: Hospitals, ophthalmic clinics, and research institutes.
Regions: North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Key factors driving market growth include:
Aging populations and higher cataract prevalence
Adoption of advanced surgical technologies
Government initiatives and NGO programs improving access to eye care
Rising awareness of vision restoration procedures
Expanding healthcare infrastructure in emerging economies
1. Aging Population and Growing Cataract Prevalence
Cataracts are strongly associated with aging, with prevalence increasing significantly in individuals over 60 years of age. As global life expectancy rises, the number of people requiring cataract surgery also increases.
By 2030, 1 in 6 people will be aged 60 years or older, up from 1 billion in 2020 to 1.4 billion.
The population aged 80 and above will triple from 2020 to 2050, reaching 426 million.
Developed countries with advanced healthcare systems and emerging economies with improving access to care are witnessing higher cataract surgery rates, driving demand for advanced devices.
Awareness programs by governments and NGOs further encourage patients to seek surgery, creating sustained demand for surgical devices and intraocular lenses (IOLs).
2. Technological Advancements in Surgery
Innovations in surgical equipment and lens technology are transforming cataract surgery, offering better outcomes and patient satisfaction.
Femtosecond lasers enhance incision precision and reduce complications.
Premium IOLs, including multifocal and toric lenses, address additional vision impairments like astigmatism and presbyopia.
Advanced phacoemulsification systems reduce procedure time and support minimally invasive approaches.
Example: In February 2024, Johnson & Johnson MedTech introduced the Tecnis PureSee lens in the EMEA region, highlighting the adoption of next-generation IOLs.
These developments not only improve surgical outcomes but also encourage patients to opt for surgeries with quicker recovery and better visual quality, expanding the market.
3. Improving Access to Eye Care in Emerging Economies
The market is growing rapidly in regions like Asia Pacific, Latin America, and Africa due to better healthcare accessibility.
Governments, NGOs, and private initiatives are improving cataract care through mobile eye clinics, subsidized surgeries, and training programs for surgeons.
Rising health insurance coverage and improving economic conditions allow more patients to afford surgeries.
Manufacturers are developing cost-effective devices suitable for high-volume, resource-limited settings, which drives adoption in emerging markets.
Challenges in the Cataract Surgery Devices Market
1. High Cost of Advanced Devices
High-end devices such as femtosecond lasers and premium IOLs remain expensive, limiting adoption:
Many patients, especially in emerging regions, cannot afford premium lenses or advanced technologies.
Even in developed countries, small clinics may struggle with high upfront costs to establish high-tech surgical setups.
Premium lenses often require out-of-pocket payment, further restraining market growth despite better surgical outcomes.
2. Shortage of Skilled Ophthalmic Surgeons
A global shortage of trained surgeons limits the effective utilization of advanced cataract surgery devices.
Many regions, especially in emerging economies, lack qualified professionals to perform surgeries.
Training and retaining skilled ophthalmologists require significant investment and time, creating a gap between supply and demand.
Underutilization of advanced devices and limited patient access hinder market growth despite technological progress and increasing awareness.
North America
The North American market, led by the US and Canada, is growing steadily:
Increasing awareness of cataract surgery benefits, combined with an aging population, drives demand.
Adoption of femtosecond lasers, premium IOLs, and phacoemulsification systems is rising.
Canada benefits from government-funded healthcare, making surgeries more accessible and affordable.
Growing obesity rates contribute indirectly, as obesity has been linked to higher cataract prevalence.
Europe
Europe is a significant contributor to the global market, with France, Germany, Italy, Spain, the UK, Belgium, Netherlands, and Turkey as major players:
Aging populations and technological adoption fuel growth.
Germany leads due to its established healthcare infrastructure, government-backed programs, and high adoption of new surgical technologies.
Example: In 2022, Carl Zeiss Meditec collaborated with Precise Bio to develop artificial corneal tissue, enhancing treatment options for keratoconus and lenticular transplants.
Asia Pacific
The Asia Pacific region is experiencing rapid growth due to increasing geriatric populations and improving healthcare infrastructure:
Key markets include Japan, Australia, China, India, South Korea, Thailand, Malaysia, Indonesia, and New Zealand.
Japan and Australia are early adopters of premium IOLs and femtosecond lasers.
China and India are emerging markets with increasing awareness, government programs, and rising healthcare investments.
The growing number of skilled ophthalmologists and preference for minimally invasive surgeries supports market expansion.
Middle East & Africa
The MEA market is expanding, with Saudi Arabia, UAE, and South Africa leading:
Increasing healthcare investments and improved awareness of cataract treatments drive demand.
Adoption of advanced surgical devices is rising as healthcare infrastructure develops.
Government support and trained ophthalmologists enhance access to modern cataract surgeries.
Latin America
Brazil, Mexico, and Argentina show steady growth due to rising awareness and improving healthcare systems.
Market Segmentation
By Product Type
Intraocular Lens (IOLs) – Multifocal, monofocal, toric lenses for vision correction
Phacoemulsification Systems – Ultrasonic devices for cataract removal
Femtosecond Laser – Precision cutting for lens extraction
Ophthalmic Viscoelastic Devices & Other Consumables – Enhance surgical safety and outcomes
By End Use
Hospitals – Major centers for cataract surgeries
Ophthalmic Clinics – Specialized eye care centers adopting advanced devices
Research Institutes – Contribute to innovation and device testing
By Geography
North America: US, Canada
Europe: France, Germany, Italy, Spain, UK, Belgium, Netherlands, Turkey
Asia Pacific: China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand
Latin America: Brazil, Mexico, Argentina
Middle East & Africa: Saudi Arabia, UAE, South Africa
Competitive Landscape
Major companies focus on innovation, product expansion, and global reach:
Alcon, Inc. – Leading in IOLs and phacoemulsification systems
Johnson & Johnson – Advanced IOLs and femtosecond lasers
Carl Zeiss Meditec AG – Femtosecond laser technology and premium IOLs
Bausch & Lomb, Inc. – Phacoemulsification devices and ophthalmic consumables
Topcon Corp – Ophthalmic diagnostic and surgical solutions
STAAR Surgical Co – Specialty IOLs and laser systems
Glaukos Corp – Advanced glaucoma and lens solutions
Abbott Laboratories – Vision care technologies and surgical instruments
These players invest heavily in R&D, partnerships, and innovative technologies, promoting better outcomes and increasing adoption of modern cataract surgery devices.
Future Outlook
The cataract surgery devices market is expected to continue steady growth due to:
Rising cataract prevalence and aging populations
Adoption of femtosecond lasers, advanced phacoemulsification systems, and premium IOLs
Improving access to eye care in emerging economies
Expansion of trained ophthalmologists and healthcare infrastructure
Increasing patient awareness and preference for high-quality vision restoration procedures
With ongoing technological innovation, government support, and global healthcare investments, cataract surgery devices are set to enhance surgical outcomes, improve patient quality of life, and transform global vision care.
Note: If you need details, data, or insights not covered in this report, we are glad to assist. Through our customization service, we will collect and deliver the information you require, tailored to your specific needs. Share your requirements with us, and we will update the report to align with your expectations.
About the Creator
Diya Dey
Market Analyst


Comments
There are no comments for this story
Be the first to respond and start the conversation.